River Global Investors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-65,297
Closed -$5.94M 147
2018
Q4
$5.94M Buy
65,297
+22,912
+54% +$2.14M 0.51% 63
2018
Q3
$4.17M Hold
42,385
0.38% 84
2018
Q2
$3.63M Buy
42,385
+1,577
+4% +$132K 0.37% 87
2018
Q1
$3.27M Sell
40,808
-1,700
-4% -$140K 0.38% 87
2017
Q4
$3.43M Buy
42,508
+11,850
+39% +$949K 0.38% 87
2017
Q3
$2.38M Hold
30,658
0.35% 87
2017
Q2
$2.72M Sell
30,658
-1,392
-4% -$117K 0.51% 71
2017
Q1
$2.58M Buy
32,050
+1,650
+5% +$129K 0.58% 67
2016
Q4
$2.17M Hold
30,400
0.61% 69
2016
Q3
$2.63M Buy
+30,400
New +$2.65M 0.83% 55
2015
Q1
Sell
-448
Closed -$32K 105
2014
Q4
$32K Buy
+448
New +$31.1K 0.01% 82

Other funds holding MDT

River Global Investors's MDT Position: Q1 2019 in Review

River Global Investors sold out of Medtronic (MDT) in Q1 2019, closing a stake of 65,297 shares — an estimated $5.94M sold.

River Global Investors first reported a position in MDT in Q4 2014 and held it in 11 quarters. The position peaked at $5.94M in Q4 2018. 1,603 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • River Global Investors reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • River Global Investors sold 65,297 Medtronic shares in Q1 2019, an estimated $5.94M.
  • River Global Investors first reported a position in Medtronic in Q4 2014 and held it in 11 quarters.
  • River Global Investors's Medtronic position peaked at $5.94M in Q4 2018.
  • 1,603 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on River Global Investors's 13F filing for Q1 2019, filed 10 May 2019.